Veeda Clinical Research receives growth capital from Sabre Partners and a group of marquee HNIs Read more
DCGI allows PNB Vesper Life Science to conduct phase-III clinical trials on PNB 001/GPP-BALACOVIN to treat COVID-19 Read more
Additional 61,120 vials of Liposomal Amphotericin B allocated to states/UTs and central institutions: Gowda Read more